{
  "id": "clinical#risk_safety_a3ca753d",
  "content": "Boundary with other mental disorders and other medical conditions\nNumerous mental disorders and subthreshold symptoms may co-occur with episodic or\ncontinuous patterns of substance use. Similarly, continuous or episodic substance use increases\nthe risk of mental disorders and other medical conditions. Co-occurring mental disorders and\ncomorbid medical conditions should be diagnosed separately, along with a diagnosis of harmful\npattern of psychoactive substance use.\nSubstance dependence\nAvailable categories by substance class\n6C40.2 Alcohol dependence\n6C41.2 Cannabis dependence\n6C42.2 Synthetic cannabinoid dependence\n6C43.2 Opioid dependence\n6C44.2 Sedative, hypnotic or anxiolytic dependence\n6C45.2 Cocaine dependence\n6C46.2 Stimulant dependence, including amfetamines, methamfetamine and\nmethcathinone\n6C47.2 Synthetic cathinone dependence\n6C49.2 Hallucinogen dependence\n6C4A.2 Nicotine dependence\n6C4B.2 Volatile inhalant dependence\n6C4C.2 MDMA or related drug dependence, including MDA\n6C4D.2 Dissociative drug dependence, including ketamine and PCP\n6C4E.2 Other specified psychoactive substance dependence\n6C4F.2 Multiple specified psychoactive substance dependence\n6C4G.2 Unknown or unspecified psychoactive substance dependence\nEssential (required) features\n• A pattern of recurrent episodic or continuous use of a psychoactive substance is required for\ndiagnosis, with evidence of impaired regulation of use of that substance that is manifested\nin two or more of the following:\n• impaired control over substance use (i.e. onset, frequency, intensity, duration, termination,",
  "metadata": {
    "source": "WHO ICD-11",
    "url": "https://icd.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "communication_tips",
      "risk_safety",
      "screening_cues"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Risk Safety Boundary with other mental disorders and other medical conditions\nNumerous mental disorders and subthreshold symptoms may co-occur with episodic or\ncontinuous patterns of substance use. Similarly, continuous or episodic substance use increases\nthe risk of mental disorders and other medical conditions. Co-occurring mental disorders and\ncomorbid medical conditions should be diagnosed separately, along with a diagnosis of harmful\npattern of psychoactive substance use.\nSubstance dependence\nAvailable categories by substance class\n6C40.2 Alcohol dependence\n6C41.2 Cannabis dependence\n6C42.2 Synthetic cannabinoid dependence\n6C43.2 Opioid dependence\n6C44.2 Sedative, hypnotic or anxiolytic dependence\n6C45.2 Cocaine dependence\n6C46.2 Stimulant dependence, including amfetamines, methamfetamine and\nmethcathinone\n6C47.2 Synthetic cathinone dependence\n6C49.2 Hallucinogen dependence\n6C4A.2 Nicotine dependence\n6C4B.2 Volatile inhalant dependence\n6C4C.2 MDMA or related drug dependence, including MDA\n6C4D.2 Dissociative drug dependence, including ketamine and PCP\n6C4E.2 Other specified psychoactive substance dependence\n6C4F.2 Multiple specified psychoactive substance dependence\n6C4G.2 Unknown or unspecified psychoactive substance dependence\nEssential (required) features\n• A pattern of recurrent episodic or continuous use of a psychoactive substance is required for\ndiagnosis, with evidence of impaired regulation of use of that substance that is manifested\nin two or more of the following:\n• impaired control over substance use (i.e. onset, frequency, intensity, duration, termination, Ranh giới with other mental disorders and other medical conditions\nnumerous mental disorders and subthreshold symptoms may co-occur with episodic or\ncontinuous patterns of substance use. similarly, continuous or episodic..."
}